Pentwater Capital Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-14,000
| Closed | -$614K | – | 124 |
|
2022
Q1 | $614K | Sell |
14,000
-25,500
| -65% | -$1.12M | 0.01% | 107 |
|
2021
Q4 | $2.4M | Buy |
39,500
+27,500
| +229% | +$1.67M | 0.03% | 85 |
|
2021
Q3 | $499K | Hold |
12,000
| – | – | 0.01% | 165 |
|
2021
Q2 | $364K | Hold |
12,000
| – | – | ﹤0.01% | 222 |
|
2021
Q1 | $358K | Hold |
12,000
| – | – | ﹤0.01% | 244 |
|
2020
Q4 | $215K | Hold |
12,000
| – | – | ﹤0.01% | 183 |
|
2020
Q3 | $229K | Sell |
12,000
-500
| -4% | -$9.54K | ﹤0.01% | 173 |
|
2020
Q2 | $197K | Hold |
12,500
| – | – | ﹤0.01% | 120 |
|
2020
Q1 | $171K | Sell |
12,500
-40,087
| -76% | -$548K | ﹤0.01% | 91 |
|
2019
Q4 | $496K | Sell |
52,587
-5,100
| -9% | -$48.1K | 0.01% | 84 |
|
2019
Q3 | $657K | Sell |
57,687
-6,135
| -10% | -$69.9K | 0.01% | 81 |
|
2019
Q2 | $642K | Buy |
+63,822
| New | +$642K | 0.01% | 96 |
|